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Summary 
The objective of this research is to develop specific T cell clones and anti- 
bodies (Abs) to study the efficiency of purifying closely associated T cells 
using Continuous Flow Electrophoresis System (CFES). Enhanced separation is 
accomplished by tagging cells first with Abs directed against the antigenic 
determinants on the cell surface and then with Abs against the Fc portion of 
the first Ab. This second Ab protrudes sufficiently beyond the cell membrane 
and glycocalyx to become the major overall cell-surface potent a1 determinant 
and thus causes a reduction of electrophoretic mobility (EPM). This project has 
been divided into three phases. Phase one included development of specific T 
cell clones and separation of these specific clones. Phase two extends these 
principles to the separation of T cells from spleen cells and 
node cells. Phase three applies this double antibody technique to the separation 
of T cytotoxic (Tc) cells from bone marrow. 
m i z e d  lymph 
Background 
Analytical Microelectrophoresis 
Microelectrophoresis has been used to quantitate the effect of Ab treatment on 
the EPM of three populations of cells viz. mouse intestinal epithelial cells 
(IEC), human mononuclear cells (HMNC) and human erythrocytes (7, 8, 12). Compar- 
ison of EPM distributions of IEC and HMNC has shown that single Ab treatment 
caused no change in EPM while double Ab treatment caused considerable reduction. 
EPM of human erythrocytes has shown that for blood group Al and N determinants 
associated with glycocalyx, a single Ab was sufficient to cause reduction while 
second Ab was needed for cell membrane-associated determinants (Rh blood group) 
(8, 10). Furthermore, the use of a cationized second Ab resulted in a higher 
reduction in EPM in a system where the antigen is presumably in the membrane. 
Single Ab treatment for membrane-associated antigens did not reduce the EPM. It 
has been proposed that the first Ab is unable to project beyond the glycocalyx 
of the cell and therefore does not cause a significant decrease in negative 
charge. However, the addition of second Ab allows the positive charges to extend 
beyond the glycocalyx resulting in an effective reduction in the normal net 
negative charge which causes the retardation of cell mobility. This hypothesis 
is illustrated in Fig. 1. It suggests that a single Ab suffices to affect EPM 
when the antigen is in the glycocalyx while second Ab is required for effective 
reduction in EPM when the antigen is in the cell membrane (Fig. 2). 
Preparative free-fluid electrophoresis 
Studies using heavy water gradient electrophoresis have used the double Ab pro- 
cedure to separate and purify intraepithelial lymphocytes (IEL) and spleen T 
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Single Antibody 
Fig. 1. Schematic representation of the effect of double Ab treatment on the 
effective charge of cells. A is a cell with its negatively charged 
glycoprotein strands sticking out. B is a cell which has Ab sticking on to 
the cell surface where the height of the Ab is similar to the height of the 
glycoprotein strands. C is a cell where the second Ab is sitting on top of the 
first Ab and extends beyond the glycocalyx. Only in the last case an effective 
decrease in EPM occurs. 
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cells (6, 7, 8). IEL from mouse small intestine, which have a 10% epithelial 
cell contamination after percoll separation, can be further purified by incuba- 
ting with rabbit IgG (to rat intestinal brush border) followed by incubation 
with goat IgG to rabbit IgG. This double Ab incubation caused a reduction of EPM 
of tagged cells sufficient to achieve an electrophoretic fraction virtually 
devoid of contaminating epithelial cells. In another application T cells were 
separated from a mixture of Ficollpypaque purified spleen cells by incubating 
cells with goat anti-mouse total immunoglobulins and then with rabbit anti-goat 
IgG. With no Ab treatment the fastest moving fraction of T cells had 20% B cell 
contamination while after double Ab treatment only 2% B cell contamination was 
found . 
One of the main problems encountered in discontinuous heavy water gradient prep- 
arative electrophoresis is the small number of cells obtained from the most pu- 
rified fraction. This restricted analysis of different fractions to phenotyping 
by cell surface immunofluorescence in lieu of testing their biological activity. 
This problem may be resolved by using the CFES which offers an increased 
throughput and resolution for separation of cells without thermoconvection- 
stabilizing additives. 
Approach 
Previous methods of cell separation like preparative electrophoresis are limit- 
ed since the sensitivity of double Ab technique is difficult to quantify by a 
biological assay. To explore the practical limits of double Ab and CFES a very 
well characterized model cell system was needed. The rationale was to generate 
two T cell clones which could differentiate between closely associated antigens. 
Sperm Whale Myoglobin ( S W M b )  and Apo-SWMb were selected as the antigens because 
they only differ in tertiary structure. The EPM of SWMb and Apo-SWMb clones will 
then be determined. If these two clones do not cross react and have unique EPMs 
they can be mixed and re-separated on CFES. If there is inadequate difference 
between the EPM distribution then Ab to known SWMb determinants can be used to 
increase the separation of SWMb and Apo-SWMb clones. After separation the frac- 
tions are tested for their biological activity using proliferative response 
assay (11). The understanding gained from the model system can then be used to 
project or predict how useful the double Ab technique will be for other selected 
target cells. 
Phase one included generation of specific T cell clones to different antigenic 
sites on SWMb or Apo-SWMb. SWMb has five well characterized antigenic sites rec- 
ognized by antibodies. Site 1 consists of residues 16-21, Site 2 consists of 
residues 56-62, Site 3 consists of 94-99, Site 4 consists of residues 113-119 
and site 5 of residues 146-151 (1, 2). Very little is known about about the mo- 
lecular parameters involved in the T cell responses to protein antigens. This 
was mainly due to the inability to prepare specific T cells to well defined pro- 
tein determinants. T cell cloning has now made it possible to prepare clones to 
well defined antigenic sites (3, 4, 9). Initial screening for T cell specifici- 
ty is done with the whole SWMb and the peptide specificity must be determined 
after second limiting dilution. The specificity of the clones is determined by 
screening their proliferative response against a pannel of overlapping peptides 
encompassing the entire SWMb. Six regions of SWMb specifically antigenic to T 
cells (T sites) were found by a comprehensive synthetic strategy to stimulate 
S'WMb-primed lymph node cells (1, 2, 5, 6, 7). The T sites are localized within 
the residues 10-22, 46-63, 69-80, 87-100, 107-120 and 137-151 (4, 13). 
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Expe r imental Results 
Before attempting to generate target clones proliferative assay was performed 
on Apo-SWMb and SWMb primed lymph node cells which were challenged by synthetic 
overlapping peptides encompassing the entire SWMb chain. In three separate ex- 
periments the response of SJL lymph node cells to Apo-SWMb was always higher 
than SWMb regardless of whether SWMb or Apo-SWMb was injected. This interesting 
finding needs to be verified further as it questions current theories about the 
mechanisms of antigen processing (5). 
SWMb clones 
After 3 passages T cells specific for SWMb were cloned by serial dilution and 
3 clones were obtained viz, A5B8, C2F5 and A2G12. The results of proliferative 
assay to test the specificity of these clones are shown in Table 2. 
Table 2: Proliferative response of SWMb clones to whole SWMB and Apo-SWMb 
Antigen Optimum dose Net cpm 
SWMb 100 ug/ml 15 I 782 
A5B8 
Apo-SWMb 12 ug/ml 95,734 
SWMb 6 W/ml 151,131 
Apo-SWMb 25 ug/ml 187,151 
C2F5 
SWMb 100 ug/ml 44 I 629 
A2G12 
APO-SWMb 25 ug/ml 43 , 573 
Apo-SWMb clones 
After first passage T cells specific for Apo-SWMb were cloned by serial 
dilution. The clones obtained were B4B6, D5Al2 and B5C1. These cells are 
now in the process of being cloned for the second time by serial dilution. 
Table 3: Prolferative response of Apo-SWMb clones to SWMb and Apo-SWMb 
Antigen 
SWMb 
APO-SWMb 
B4B6 
Optimum Dose Net cpm 
100 ug/ml 16 I 650 
25 ug/ml 11 I 781 
SWMb 12 ug/ml 4 , 214 
APo-SWMb 12 ug/ml 5 , 928 
D5Al2 
SWMb 6 ug/ml 48 , 140 
APo-SWMb 50 ug/ml 48 , 152 
B5Cl 
As indicated in Table 2 A5B8 SWMb clone has a higher response to Apo-SWMb than 
SWMb and in Table 3 the proliferative response of Apo-SWMb clones is similar. 
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Future Work 
The next phase will apply the double Ab technique to enhance the separation of 
spleen T and B cells. After separation, different fractions will be tested for 
their phenotypic determinants and mitogenic responses to conconavalin A and 
lipopolysaccharide The mitogenic response is still a very crude indicator for 
the purity of T cells or B cells therefore the next step will be to separate T 
cells from lymph node cells of immunized mice using double Ab and then test 
their functional activity by a proliferative assay. 
Phase three involves the removal of Tc cells from bone marrow then treatment 
by Ab tagging followed by free-fluid electrophoresis. The procedure would 
involve the employment of a battery of Abs specific for Tc to determine if 
single Ab or double Ab treatment is required to remove Tc cells. This approach 
could have great clinical significance e.g. "purging" of Tc cells from bone 
marrow for patient therapy and transplantation. Bone marrow transplants would 
require elimination of only Tc cells (which cause the immune rejection of bone 
marrow) followed by injection of all remaining cells back into the host. 
Conclusions 
To date the effect of double Ab treatment to alter the net surface charge of 
living cells has been documented by analytical electrophoresis. This technique 
also has been used to purify spleen T and intestinal IEL population by prepara- 
tive electrophoresis using a heavy water gradient. To better define the extent 
to which this technique can be applied to different target cells a model T clone 
system is being developed. Apo-SWMb and SWMb are two almost identical proteins 
for which specific clones have been generated. These clones will be studied for 
antigen processing and cell separation on ACE 710 and CFES. Other cell systems 
proposed to be separated are T cells from spleen, and lymph nodes and Tc from 
bone marrow. The CFES will be evaluated for efficiency in separating these 
target cells to determine if standard technique or double Ab enhancement will be 
sufficient to accomplish the desired cell separation. If not, this data will be 
used to develop proposals for flight experiments to use CFES in microgravity 
where the CFES resolution and throughput are enhanced. 
Experimental Procedures 
Proliferative Assay 
SJL mice were immunized subcutaneously at the base of the tail with 10 ug/mouse 
of major component (No 10) of Sperm Whale Myoglobin (SWMb) emulsified in 
Freund's complete adjuvant containing Mycobacterium Tuberculosis, strain H37Ra 
(Difco, Detroit, MI). Seven days after immunization, the inguinal and periaortic 
lymph node cells were harvested and the proliferative activity assessed. In a 
typical assay, lymph node cells suspended in WMI-1640 containing 1% normal 
mouse serum were challenged, in triplicate, with various concentrations of 
antigens and mitogens in 96-well tissue culture plates. After 3 days the cul- 
tures were pulsed (18 hrs) with l uCi (3H) thymidine and then harvested onto a 
glass fiber filters for counting by liquid scintilation. 
Long term T cell culture 
The basic approach to obtain and process long term T cell culture is indicated 
in Fig. 3. Cultured T cells will be separated on CFES, cloned and tested for 
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their specificity by proliferative assay. Furthermore, long term T cell culture 
will be cloned separately and their specificity tested by proliferative assay. 
Clones specific to SWMb long term T cell cultures were prepared as follows. 
SWMb primed lymph node cells were suspended in RPMI 1640 supplemented with 10% 
fetal bovine serum. The cells (2ml/well) were cultured for 4 days in 24-well 
flat bottom tissue culture treated polystyrene plates with antigen, harvested 
and then separated on ficoll-hypaque. The cell were recultured with filler 
cells (X-irradiated, 3300 R, syngeneic spleen cells) in 16 mm wells. Fourteen 
days later, fluorescein diacetate positive cells were restimulated with the 
appropriate antigen and filler cells. At 10-12 day intervals, antigen reactive 
cells were harvested, combined with additional filler cells and restimulated 
with antigen. T cell clones from protein specific bulk culture were isolated by 
limiting dilution at a frequency of 1, 0.5 and 0.25 cellfiell. The clones were 
maintained by repeated passage with antigen, filler cells and serum. Specificity 
of the T cells was determined by their proliferative response. Long term culture 
of T cells were cocultured with antigens and mitogens in RPMI supplemented with 
10% serum. Filler cells were added for macrophage source and the cells were cul- 
tured for 3 days and then pulsed with l uCi (3H) thymidine as described above. 
Preparation and purification of synthetic peptides. 
The synthetic peptides were based on the known primary structure of SwMb. The 
peptides were prepared by solid phase synthesis (11). The primary structure of 
the SWMb synthetic overlapping peptides was synthesized. Except for the carboxy- 
terminal peptide 141-153, the peptides are uniform in length (17 residues) and 
overlap adjacent peptides by 5 amino acids. SWMb sites 1, 2, 3 and 4 which were 
extended by an additional 5-6 residues (i.e. a total of 13 residues) also were 
synthesized. 
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